Molecular basis of γδ T lineage specification

γδ T 谱系规范的分子基础

基本信息

  • 批准号:
    10226992
  • 负责人:
  • 金额:
    $ 200.43万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-05-15 至 2024-07-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY/ABSTRACT Despite the growing appreciation for the critical role played by γδ T cells in host defense and immunopathology, the molecular events controlling their development and effector function remain poorly understood. Our program seeks to fill this gap in knowledge using genome-wide approaches that ultimately focus on key regulatory nodes. During the last funding cycle, we provided compelling evidence that the commitment of T cell progenitors to the αβ and γδ T cell fates depends on differences in T cell receptor (TCR) signal strength. These signaling differences regulate fate by proportional induction of Id3, which causes graded repression of the function of E box DNA binding proteins (E proteins). Using genome-wide approaches to define changes in E protein-DNA binding, we generated a number of novel insights into the control of γδ T lineage specification, which can be distilled into 3 themes: Theme 1) E protein specificity – E protein family members exhibit distinct responses to the TCR signals of differing intensity/duration that specify fate and play distinct roles in supporting γδ T cell development (Proj1/3/4); Theme 2) Non-coding transcription - E protein binding is extensively associated long non-coding RNAs (lncRNA), such as ThymoD (all Projects), Importantly, Project 4 has developed novel imaging approaches to study lncRNA function, by visualizing lncRNA promotion of chromosome looping in real time in live cells; and Theme 3) Human γδ development - Project 3 developed a novel human pluripotent stem cell (PSC) based system for studying human γδ T cell development, which revealed a requirement for HEB. In our renewal application, we will explore these themes by integrating the complementary skills of the four project leaders. The Zúñiga-Pflücker lab, together with Michele Anderson, will focus on the specific roles of E protein family members, and their responsiveness to Id-mediated repression, in orchestrating lineage commitment in mouse (theme 1) and human (theme 3) differentiation models. Their observations will inform the efforts of the Murre lab to understand the molecular basis by which E protein family members control ThymoD expression, a lncRNA (theme 2), which orchestrates both the onset of αβ lineage commitment and the ultimate loss of αβ fate potential upon γδ lineage commitment. The efforts of both the Zúñiga-Pflücker and Murre labs will enable the Wiest lab (with Dietmar Kappes) to understand the role of E protein family members and non-coding transcription (theme 2) in specifying the IL-17 producing effector fate through E protein binding sites near the Tcf7 and Zbtb7b loci. Finally, all Projects will inform efforts of Zhuang to understand how E protein family members (theme 1) and non-coding transcription (theme 2) control the generation and function of the stereotyped γδ TCR complexes that drive NKγδT cell development. All projects will continue to rely on the genomic expertise of Core B to assess the implications of destroying E protein binding sites on the genomic architecture, and then link those changes to cell fate. The collective efforts of these four projects promise to provide great insight into the role of E proteins in controlling both γδ development and function, which is of critical importance to human health and disease.
项目总结/文摘

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DAVID L. WIEST其他文献

DAVID L. WIEST的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DAVID L. WIEST', 18)}}的其他基金

Functional Analysis of Variants Underlying T Cell Defects
T 细胞缺陷变异的功能分析
  • 批准号:
    10024573
  • 财政年份:
    2020
  • 资助金额:
    $ 200.43万
  • 项目类别:
Functional Analysis of Variants Underlying T Cell Defects
T 细胞缺陷变异的功能分析
  • 批准号:
    10462634
  • 财政年份:
    2020
  • 资助金额:
    $ 200.43万
  • 项目类别:
ThymUS 2020 International Conference on Lymphopoiesis
ThymUS 2020 国际淋巴细胞生成会议
  • 批准号:
    9913243
  • 财政年份:
    2020
  • 资助金额:
    $ 200.43万
  • 项目类别:
Functional Analysis of Variants Underlying T Cell Defects
T 细胞缺陷变异的功能分析
  • 批准号:
    10256631
  • 财政年份:
    2020
  • 资助金额:
    $ 200.43万
  • 项目类别:
The ThymUS 2016 International Conference on Lymphopoiesis
ThymUS 2016 国际淋巴细胞生成会议
  • 批准号:
    8986580
  • 财政年份:
    2016
  • 资助金额:
    $ 200.43万
  • 项目类别:
Regulation of Hematopoiesis by Ribosomal Protein Paralogs
核糖体蛋白旁系同源物对造血的调节
  • 批准号:
    8816656
  • 财政年份:
    2015
  • 资助金额:
    $ 200.43万
  • 项目类别:
Molecular Basis for gamma/delta T Lineage Specification
gamma/delta T 谱系规范的分子基础
  • 批准号:
    8608275
  • 财政年份:
    2014
  • 资助金额:
    $ 200.43万
  • 项目类别:
Regulation of Hematopoiesis By Ribosomal Protein Paralogs
核糖体蛋白旁系同源物对造血的调节
  • 批准号:
    8880580
  • 财政年份:
    2014
  • 资助金额:
    $ 200.43万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    8608280
  • 财政年份:
    2014
  • 资助金额:
    $ 200.43万
  • 项目类别:
Regulation of hematopoiesis by ribosomal protein paralogs
核糖体蛋白旁系同源物对造血的调节
  • 批准号:
    10548846
  • 财政年份:
    2014
  • 资助金额:
    $ 200.43万
  • 项目类别:

相似海外基金

Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
  • 批准号:
    24K16436
  • 财政年份:
    2024
  • 资助金额:
    $ 200.43万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
  • 批准号:
    10093543
  • 财政年份:
    2024
  • 资助金额:
    $ 200.43万
  • 项目类别:
    Collaborative R&D
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
  • 批准号:
    24K16488
  • 财政年份:
    2024
  • 资助金额:
    $ 200.43万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 200.43万
  • 项目类别:
    EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
  • 批准号:
    24K20973
  • 财政年份:
    2024
  • 资助金额:
    $ 200.43万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 200.43万
  • 项目类别:
    EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
  • 批准号:
    481560
  • 财政年份:
    2023
  • 资助金额:
    $ 200.43万
  • 项目类别:
    Operating Grants
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
  • 批准号:
    10075502
  • 财政年份:
    2023
  • 资助金额:
    $ 200.43万
  • 项目类别:
    Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
  • 批准号:
    10089082
  • 财政年份:
    2023
  • 资助金额:
    $ 200.43万
  • 项目类别:
    EU-Funded
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
  • 批准号:
    2321091
  • 财政年份:
    2023
  • 资助金额:
    $ 200.43万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了